London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here


Come to London

video-icon

WATCH to find out why


Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Posters

Search Abstracts by author or title
(results will display both Free Papers & Poster)

Excimer laser additional correction of ametropia with elevation of flap previously formed during femtosecond lenticule extraction

Poster Details

First Author: O.Kostin RUSSIA

Co Author(s):    S. Rebrikov   A. Ovchinnikov   A. Stepanov        

Abstract Details



Purpose:

Estimation of reoperation with MEL 80 excimer laser after FLEx operation.

Setting:

IRTC Eye Microsurgery Ekaterinburg Center

Methods:

The study involved 720 patients (1437 eyes). In all the eyes initially FLEx operation with VisuMax femtosecond laser (Carl Zeiss Meditec) was performed. In 6 patients (9 eyes) reoperation with MEL 80 excimer laser (Carl Zeiss Meditec) was performed 12 months later due to regression of refractive effect.

Results:

Uncorrected visual acuity before FLEx operation was 0.04 ± 0.02; at day 1 post-op it made 0.69 ± 0.21 (p<0.05). Spherical equivalent before FLEx was -6.17 ± 2.56 D; at day 1 post-op it made - 0.18 ± 0.33 D (p<0.05). Corrected visual acuity was 0.99 ± 0.02 before FLEx and 0.79 ± 0.22 (p<0.05) at day 1 post-op. In 1 year after FLEx operation (before reoperation) uncorrected visual acuity was 0.26 ± 0.19; by 3 months after reoperation it made 0.96 ± 0.07 (p<0.05). Spherical equivalent before reoperation was -1.6 ± 1.12 D and made - 0.03 ± 0.08 D (p<0.05) by 3 months after reoperation. Corrected visual acuity before reoperation was 0.96 ± 0.07; by 3 months after reoperation it made 0.98 ± 0.04 (p>0.05).

Conclusions:

Excimer laser additional correction of ametropia may be successfully used after femtosecond laser extraction of corneal lenticula. FINANCIAL INTEREST: NONE

Back to Poster listing